Ted W. Love

The three purchases by Ted W. Love add up to EUR 229,729: EUR 92,773 and EUR 46,387 on August 17, 2015 at Global Blood Therapeutics, Inc., then EUR 90,570 on February 2, 2017 at Cascadian Therapeutics, Inc. They make up 13% of open-market trades, most of which remain sales: 20 of them, worth EUR 14.8 million with a median of EUR 464,644, all at Global Blood Therapeutics, Inc. The three largest: EUR 2,952,960 on April 28, 2020, EUR 2,373,777 on January 22, 2020 and EUR 2,165,388 on January 21, 2020.

The record holds 116 filings spread over 8 companies, among them Global Blood Therapeutics, Inc. (84), Cascadian Therapeutics, Inc. (8), Royalty Pharma plc (6), Seagen Inc. (5) and Amicus Therapeutics, Inc. (5). It also contains 50 grants, 27 option exercises and 16 filings of another type.

The annual peak is 2022 with 23 filings, ahead of 2020 (22) and 2019 (20); 2025 and 2026 have 2 each. At Global Blood Therapeutics, Inc., 20 trades by Ted W. Love fall within 30 days of a trade by Tricia Borga Suvari and 17 for Joshua Lehrer-Graiwer, all in the same direction.